Driving Under the Influence of Marijuana and Illicit Drugs Among Persons Aged ≥16 Years — United States, 2018 Alejandro Azofeifa, DDS; Bárbara D. Rexach-Guzmán, MPH; Abby N. Hagemeyer, PhD; Rose A. Rudd, MSPH; Erin K. Sauber-Schatz, PhD Morbidity and Mortality Weekly Report, 2019, 68, (50), 1153-1157. https://www.medscape.com/viewarticle/923059?nlid=133476_425&src=WNL_mdplsfeat_200114_mscpedit_psyc&uac=292598PZ&spon=12&impID=2244648&faf=1 Abstract and Introduction Introduction In the United States, driving while impaired is illegal. Nonetheless, an estimated 10,511 alcohol-impaired driving deaths occurred in 2018.* The contribution of marijuana and other illicit drugs to these and other impaired driving deaths remains unknown. Data from the Substance Abuse and Mental Health Services Administration's National Survey on Drug Use and Health (NSDUH) indicated [...]
Lire la suiteCannabis Use Rising Faster Among Depressed Americans Lisa Rapaport Medscape - Dec 26, 2019. https://www.medscape.com/viewarticle/923160?nlid=133282_2052&src=WNL_mdplsnews_200103_mscpedit_psyc&uac=292598PZ&spon=12&impID=2232271&faf=1 (Reuters Health) - Regular cannabis use has risen more quickly among people with depression, and they're less likely to perceive it as risky, compared with people who aren't depressed, a U.S. study suggests. Researchers examined data collected from a total of almost 729,000 people aged 12 years and older between 2005 and 2017, including any prior-month cannabis use and any depression experienced over the previous year. By the final year of the study, about 19% of people with depression reported at least some cannabis use, compared with 8.7% of individuals without a recent history of [...]
Lire la suiteTwitter Bots Tout Cannabis as a Cure-all Despite Few Approved Medical Uses Lisa Rapaport Medscape - Dec 27, 2019. https://www.medscape.com/viewarticle/923184?nlid=133282_2052&src=WNL_mdplsnews_200103_mscpedit_psyc&uac=292598PZ&spon=12&impID=2232271&faf=1 (Reuters Health) - Social media bots are promoting cannabis as a remedy for everything from cancer to insomnia and foot pain, according to an analysis of posts on Twitter. "Social bots regularly perpetuate unsubstantiated health claims on the platform, providing one example of how false statements may drown out solid science on social media," said lead study author Jon-Patrick Allem of the Keck School of Medicine at the University of Southern California in Los Angeles. "I want the public to be aware of the difference between a demonstrated, scientifically backed [...]
Lire la suiteTwo-thirds of Americans support marijuana legalization By Andrew Daniller Pew Research Center, FactTank, November 14, 2019 https://www.pewresearch.org/fact-tank/2019/11/14/americans-support-marijuana-legalization/?utm_source=AdaptiveMailer&utm_medium=email&utm_campaign=19-11-07%20Marijuana%20Legalization%20Heads-up&org=982&lvl=100&ite=4914&lea=1115963&ctr=0&par=1&trk= Two-thirds of Americans say the use of marijuana should be legal, reflecting a steady increase over the past decade, according to a new Pew Research Center survey. The share of U.S. adults who oppose legalization has fallen from 52% in 2010 to 32% today. Meanwhile, an overwhelming majority of U.S. adults (91%) say marijuana should be legal either for medical and recreational use (59%) or that it should be legal just for medical use (32%). Fewer than one-in-ten (8%) prefer to keep marijuana illegal in all circumstances, according [...]
Lire la suiteMarijuana and acute health care contacts in Colorado George SamWang, Katelyn Hall, Daniel Vigil, Shireen Banerji, AndrewMonte, Mike VanDyke Preventive Medicine, 2017, 104, 24-30. doi: 10.1016/j.ypmed.2017.03.022 a b s t r a c t Over 22 million Americans are current users of marijuana; half of US states allow medical marijuana, and several allow recreational marijuana. The objective of this study was to evaluate the impact marijuana has on hospitalizations, emergency department (ED) visits, and regional poison center (RPC) calls in Colorado, a medical and recreational marijuana state. This is a retrospective review using Colorado Hospital Association hospitalizations and ED visits with marijuana-related billing codes, and [...]
Lire la suiteCalifornia Psilocybin Decriminalization Initiative The Beckley Foundation is proud to announce its partnership with Decriminalize California (the California Psilocybin Decriminalization Initiative 2020), an open-source citizens’ initiative which would: legalize psilocybin mushrooms and their extracts and derivatives for therapeutic and medical use, and decriminalize it for personal, spiritual and religious use; allowing people to cultivate and use psilocybin mushrooms in their own home and on privately-owned property; and enabling those convicted of psilocybin-related crimes to have their sentences reviewed and, when appropriate, have their criminal records expunged. You can read the full press release here. The initiative decriminalizes psilocybin use by adults aged 18+. [...]
Lire la suiteUS Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws 1991-1992 to 2012-2013 Deborah S. Hasin, Aaron L. Sarvet, Magdalena Cerda, Katherine M. Keyes, Malka Stohl, Sandro Galea, Melanie M. Wall JAMA Psychiatry, 2017, 74, (6), 579–610. Doi : 10.1001/jamapsychiatry.2017.0724 PMCID: PMC5539836 PMID: 28445557 Key Points Question Are US state medical marijuana laws one of the underlying factors for increases in risk for adult cannabis use and cannabis use disorders seen since the early 1990s? Findings In this analysis using US national survey data collected in 1991-1992, 2001-2002, and 2012-2013 from 118 497 participants, the risk for cannabis use and cannabis use disorders increased at a significantly [...]
Lire la suiteUne université de Houston teste la psilocybine pour la dépression résistante aux traitements - www.NEWSWEED.fr 22 octobre 2019 Aurélien BERNARD Dans la foulée de sa décriminalisation dans quelques villes des États-Unis (Oakland et Denver notamment), la psilocybine intéresse actuellement la communauté scientifique à la recherche de preuves d’efficacité thérapeutique. Des chercheurs du Science Health Center de l’Université du Texas à Houston (UTHealth) ont annoncé qu’ils étudiaient la psilocybine pour la dépression réfractaire aux traitements. PUBLICITE L’étude est inspirée par des recherches scientifiques antérieures qui suggèrent que la psilocybine agit pour créer de nouveaux circuits mentaux. Une étude de 2012 a conclu que la substance pouvait permettre [...]
Lire la suiteA Psychotherapeutic View on the Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of Addiction Anja LOIZAGA-VELDER MAPS Bulletin Special Edition, Spring 2013, 36-40. Ayahuasca is a traditional plant preparation of the Amazon basin with psychoactive properties. In recent decades ayahuasca has gained the attention of researchers in multiple disciplines worldwide due to its acclaimed therapeutic and spiritual qualities. It is an admixture of two plants : the harmaline containing vine Banisteriopsis caapi, and the DMT-containing leafs from the Psychotria viridis bush. It is typically administered by a trained expert in a ritual context. The use of ayahuasca has spread beyond the Amazon [...]
Lire la suiteLifetime marijuana use in relation to insulin resistance in lean, overweight, and obese US adults Gerard Ngueta, Ruth Ndjaboue Journal of Diabetes, 2019 https://doi.org/10.1111/1753-0407.12958 Abstract Background Obese individuals are more likely to show insulin resistance (IR). However, limited population studies on marijuana use with markers of IR have yielded mixed results. The aim of this study was to examine the association of marijuana use with IR in US adults with different body mass index (BMI) status. Methods Data from the 2009 to 2016 National Health and Nutrition Examination Survey (NHANES) were abstracted. Minimal lifetime marijuana use was estimated using the duration of regular exposure and frequency of use. [...]
Lire la suite